$LMNX News
Last published 2mo ago
- 2mo agoAHCOLMNXDDDAdaptHealth Appoints Harriss Currie as Chief Financial OfficerBusiness WireAdaptHealth Corp. (NASDAQ:AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and
- 2mo agoLMNXZETXDKNXOKLS+2Defiance ETFs Announces Closure of Select FundsGlobeNewswireNEW YORK, Aug. 21, 2026 (GLOBE NEWSWIRE) -- Tidal Financial Group and Defiance ETFs today announced their decision to close and liquidate eight exchange-traded funds listed on various exchanges as indicated below:
- 5y agoLMNXMSEXSPGIMiddlesex Water Set to Join S&P SmallCap 600PR NewswireNEW YORK, July 12, 2021 /PRNewswire/ -- Middlesex Water Co. (NASD: MSEX) will replace Luminex Corp. (NASD: LMNX) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, July 15. DiaSorin S.p.A. is acquiring Luminex in a deal expec
- 5y agoLMNXLuminex Corporation Declares Second Quarter Cash DividendPR NewswireAUSTIN, Texas, May 20, 2021 /PRNewswire/ -- Luminex Corporation (NASDAQ:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the second quarter of 2021 of $0.10 per share of common stock payable on July 8, 2021�
- 5y agoHCICLMNXSOLYSTPCMoore Kuehn Encourages LMNX, STPC, HCIC, and SOLY Investors to Contact Law FirmPR NewswireNEW YORK, May 14, 2021 /PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shar
- 5y agoNUANLMNXCADEORBCMoore Kuehn Encourages NUAN, LMNX, CADE, and ORBC Investors to Contact Law FirmPR NewswireMoore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims...
- 5y agoLMNXDiaSorin to acquire Luminex Corporation for USD 37.00 per share or approximately USD 1.8 billionPR NewswireDiaSorin S.p.A. ("DiaSorin"; FTSE MIB: DIA) today announced that its Board of Directors has unanimously approved and signed a definitive merger...
- 5y agoGSLMNXEuropean Stocks Pause Record Rally as Focus Shifts to EarningsBloomberg
- 5y agoMSLMNXDiaSorin to Buy Covid-19 Test-Maker Luminex for $1.8 BillionBloomberg
- 5y agoLMNXLuminex Submits Joint SARS-CoV-2 and Flu/RSV Respiratory Panel to FDA for Emergency Use AuthorizationPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has submitted an Emergency Use Authorization application to the U.S. Food and Drug...
- 5y agoLMNXLuminex Corporation to Participate at the 2021 Barclays Global Healthcare ConferencePR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, Chairman, CEO & President, and Harriss Currie, Senior Vice President and CFO,...
- 5y agoLMNXLuminex Receives FDA Emergency Use Authorization and CE Mark for Expanded NxTAG® Respiratory Panel Test Including SARS-CoV-2PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration...
- 5y agoLMNXDiaSorin Weighs Diagnostics Deal for LuminexBloombergItalian diagnostics company DiaSorin SpA is considering an acquisition of rival Covid-19 testing-kit maker Luminex Corp., according to people familiar with the matter.
- 5y agoLMNXLuminex Receives BARDA Funding to Support Development and Validation of Test Combining SARS-CoV-2 and Flu/RSV Respiratory PanelPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has received $11.3 million in funding from the Biomedical Advanced Research and...
- 5y agoLMNXLuminex Corporation Reports Fourth Quarter and Full-Year 2020 ResultsPR NewswireLuminex Corporation (Nasdaq: LMNX) today announced results for its fourth quarter and full-year ended December 31, 2020. All amounts in this release...
- 5y agoLMNXLuminex Corporation Declares First Quarter Cash DividendPR NewswireLuminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the first quarter of 2021...
- 5y agoLMNXLuminex Corporation Fourth Quarter Earnings Release Scheduled for February 8, 2021PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the fourth quarter ended December 31, 2020 on Monday, February ...
- 5y agoLMNXLuminex Corporation to Present at 39th Annual J.P. Morgan Healthcare ConferencePR NewswireAs previously announced, Luminex Corporation (Nasdaq: LMNX) will present at the 39th Annual J.P. Morgan Healthcare Conference, to be held virtually...
- 5y agoLMNXLuminex Corporation Pre-Release of 4th Quarter 2020 RevenuePR NewswireLuminex Corporation (Nasdaq: LMNX) today announced 4th quarter 2020 revenue of approximately $111M, up approximately 23% over the 4th quarter of 2019 ...
- 5y agoLMNXLuminex Corporation to Present at 39th Annual J.P. Morgan Healthcare ConferencePR NewswireLuminex Corporation (Nasdaq: LMNX) today announced that Nachum "Homi" Shamir, Chairman, CEO and President, and Harriss Currie, Senior Vice President...
- 5y agoLMNXLuminex Corporation Declares Fourth Quarter Cash DividendPR NewswireOn December 3, 2020, Luminex Corporation (Nasdaq:LMNX) (the "Company"), announced that its board of directors approved a $0.01 increase in the...
- 5y agoLMNXNew patent granted for: Methods and Systems for Image Data ProcessingUS Patent Applications (USPTO)
- 5y agoLMNXNew patent granted for: Method to Combine Brightfield and Fluorescent Channels for Cell Image Segmentation and Morphological Analysis Using Images Obtained From Imaging Flow Cytometer (ifc)US Patent Applications (USPTO)
- 6y agoLMNXLuminex Corporation Reports Strong Third Quarter 2020 ResultsPR NewswireLuminex Corporation (Nasdaq: LMNX) today announced results for its third quarter ended September 30, 2020. All amounts in this release are in...
- 6y agoLMNXLuminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the third quarter ended September 30, 2020 on Thursday,...
- 6y agoLMNXLuminex Corporation Pre-Release of 3rd Quarter 2020 RevenuePR NewswireLuminex Corporation (Nasdaq: LMNX) today announced 3rd quarter 2020 revenues of approximately $106 million, up approximately 35% over the 3rd quarter ...
- 6y agoLMNXLuminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has received a $5,389,813 award from the Biomedical Advanced Research and Development...
- 6y agoLMNXLuminex Receives BARDA Award to Support Enhancement of COVID-19 Multiplex Antibody TestPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has received an award of $683,500 from the Biomedical Advanced Research and Development...
- 6y agoLMNXLuminex Corporation Declares Third Quarter Cash DividendPR NewswireOn September 10, 2020, Luminex Corporation (Nasdaq:LMNX) (the "Company"), announced that its board of directors declared a cash dividend for the...
- 6y agoLMNXLuminex Corporation (LMNX) CEO Nachum Shamir on Q2 2020 Results- Earnings Call TranscriptEarnings Call Transcripts
- 6y agoLMNXLuminex Corporation Announces Departure of G. Walter Loewenbaum from Its Board of DirectorsPR NewswireLuminex Corporation (Nasdaq: LMNX) today announced the retirement of its Chairman, G. Walter Loewenbaum, from its Board of Directors ("Board")...
- 6y agoLMNXLuminex Corporation Reports Second Quarter 2020 ResultsPR NewswireLuminex Corporation (Nasdaq: LMNX) today announced results for its second quarter ended June 30, 2020. All amounts in this release are in conformity...
- 6y agoLMNXLuminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG®...
- 6y agoLMNXLuminex Corporation Second Quarter Earnings Release Rescheduled for August 4, 2020PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2020 on Tuesday, August 4,...
- 6y agoLMNXLuminex Receives FDA Emergency Use Authorization for COVID-19 Antibody TestPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for...
- 6y agoLMNXCoronavirus (COVID-19) Update: Daily Roundup July 17, 2020FDA Press ReleasesThe U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part of the FDA’s effort to protect consumers, the agency issued warning letters to operators of two websites (www.hydroxychloroquine-online.com and www.pharmaboosters.com) that market unapproved COVID-19 products. There are currently no FDA-approved drugs t ...
- 6y agoLMNXLuminex Corporation Pre-Release of 2nd Quarter 2020 RevenuePR NewswireLuminex Corporation (Nasdaq: LMNX) today announced 2nd quarter 2020 revenues of between $109 and $110 million, up more than 30% over the 2nd quarter...
- 6y agoLMNXLuminex Corporation Pre-Release of 2nd Quarter 2020 RevenuePR NewswireLuminex Corporation (Nasdaq: LMNX) today announced 2nd quarter 2020 revenues of between $109 and $110 million, up more than 30% over the 2nd quarter...
- 6y agoLMNXLuminex Delivers xMAP® INTELLIFLEX Systems to Life Science Research PartnersPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its...
- 6y agoLMNXLuminex Submits Emergency Use Authorization Request to U.S. FDA for COVID-19 Antibody TestPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug...
- 6y agoLMNXLuminex Corporation Announces Pricing Of Offering Of $260 Million Of 3.00% Convertible Senior Notes Due 2025PR NewswireLuminex Corporation (NASDAQ: LMNX) ("Luminex") announced today the pricing of its offering of $260,000,000 aggregate principal amount of 3.00%...
- 6y agoLMNXLuminex Corporation Reports First Quarter 2020 ResultsPR NewswireLuminex Corporation (Nasdaq: LMNX) today announced results for its first quarter ended March 31, 2020. All amounts in this release are in conformity...
- 6y agoLMNXLuminex Corporation First Quarter Earnings Release Rescheduled for May 4, 2020PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the first quarter ended March 31, 2020 on Monday, May 4, 2020. ...
- 6y agoLMNXLuminex Receives FDA Emergency Use Authorization for ARIES® SARS-CoV-2 Assay to Detect Virus Responsible for COVID-19 DiseasePR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for...
- 6y agoLMNXLuminex Receives BARDA Contract to Support Development of Second, Rapid SARS-CoV-2 TestPR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that it has received $642,450 in funding from the Biomedical Advanced Research and Development...
- 6y agoLMNXLuminex Receives FDA Emergency Use Authorization for NxTAG® CoV Extended Panel to Detect the SARS-CoV-2 Virus that Causes COVID-19 DiseasePR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for...
- 6y agoLMNXLuminex Provides Update on SARS-CoV-2 Validation Testing EffortsPR NewswireLuminex Corporation (NASDAQ: LMNX) announced today that four independent clinical laboratories have validated laboratory developed tests (LDTs) for...
- 6y agoLMNXLuminex Corporation Submits VERIGENE® II Respiratory Flex Assay for FDA ClearancePR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that the company has submitted an application to the U.S. Food and Drug Administration (FDA) for...
- 6y agoLMNXLuminex Corporation Declares First Quarter Cash DividendPR NewswireLuminex Corporation (Nasdaq:LMNX) (the "Company") today announced that its board of directors declared a cash dividend for the first quarter of 2020...
- 6y agoLMNXLuminex Corporation to Participate At Upcoming Healthcare Investor Conferences in March 2020PR NewswireLuminex Corporation (NASDAQ: LMNX) today announced that Homi Shamir, President & CEO, and Harriss Currie, Senior Vice President of Finance and CFO,...